France· FR:68163833
DIPROSTENE, suspension injectable en seringue pré-remplie
A medicinal product containing bétaméthasone (phosphate disodique de) + dipropionate de bétaméthasone, registered in France by ORGANON FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BÉTAMÉTHASONE (PHOSPHATE DISODIQUE DE) + DIPROPIONATE DE BÉTAMÉTHASONE
- Manufacturer
- ORGANON FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009320050931 seringue(s) préremplie(s) de 1 ml en verre avec aiguille(s)EUR 4.29
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bétaméthasone (phosphate disodique de) + dipropionate de bétaméthasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAudavate 0.1% creamAccord-UK Ltd
- United Statesbetamethasone dipropionateViona Pharmaceuticals Inc
- Japanベタメタゾン扶桑薬品工業
- BelgiumBetatape 2,250 mgIBSA Farmaceutici Italia
- ItalyALBAFLOEBERLIFE FARMACEUTICI S.P.A.
- CanadaBETADERM CRM 0.05%TARO PHARMACEUTICALS INC
- FinlandBemetsonOrion Corporation
- NorwayBetaGalenGALENpharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Betnesol, Betnovate
- Belgium · Betnelan V, Celestone
- Bulgaria · Бетазон, Бетазонтаб
- Cyprus · Betnovate, Medobeta
- Czechia · Beloderm, Diprosone
- Germany · Betagalen, Betagalen Lotion
- Denmark · Bekuval, Bemeson
- Estonia · Betnovate
- Spain · Betametasona Sonphar, Betnovate Crema
- Finland · Bemetson, Betapred
- United Kingdom (Northern Ireland) · Audavate, Audavate Rd
- Greece · Betnovate, Flogozyme
- Croatia · Beloderm, Betamethasone Jgl
- Hungary · Betesil
- Ireland · Betacap Scalp Application, Betnovate
- Iceland · Betnovat
- Italy · Betamesol, Betametasone Dipropionato Sandoz
- Lithuania · Celestoderm–v
- Luxembourg · Betnelan V, Celestone
- Latvia · Celestoderm-V
- Malta · Betnovate
- Netherlands · Betamethason Teva, Betamethason Xiromed
- Norway · Betnovat, Diprotit
- Poland · Beloderm, Diprolene
- Portugal · Betametasona Basi, Betnovate
- Romania · Betaderm, Betametazonă Fiterman
- Sweden · Betametason Evolan, Betapred
- Slovenia · Beloderm, Flosteron
- Slovakia · Beloderm, Beloderm Lotion
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2b0bd1f-7bde-41f2-ad2e-77cba56abbc4 GET /v1/drugs/a2b0bd1f-7bde-41f2-ad2e-77cba56abbc4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68163833",
"date_amm": "1998-03-12",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BÉTAMÉTHASONE (PHOSPHATE DISODIQUE DE) + DIPROPIONATE DE BÉTAMÉTHASONE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension injectable",
"voies_administration": "endosinusale;intraarticulaire;intralésionnelle;intramusculaire;périarticulaire",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bétaméthasone (phosphate disodique de) + dipropionate de bétaméthasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.